Answers are grounded in this paper and cite their sources.
Comments and Correction1 August 1976Daunomycin, Adriamycin, and Recall EffectDAVID BAER, M.D., LEE S. WILKINSON, M.D.DAVID BAER, M.D.Search for more papers by this author, LEE S. WILKINSON, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-85-2-259_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Recent reports (1, 2) of varieties of "recall phenomena" associated with adriamycin administration prompt us to describe a similar event in a patient given daunomycin after adriamycin.A 28-year-old woman was found on routine examination to have a 3-cm mass in her right anterior cervical triangle. After the mass enlarged during observation, an excisional biopsy showed a diffuse, poorly differentiated, lymphocytic lymphoma. The tumor was invading the surrounding soft tissue. Staging procedures (including bilateral iliac crest biopsies, a lymphangiogram, a gallium scan, and a staging laparotomy) failed to show disease outside of the clinically involved area. Because...References1. DONALDSON S, GLICK J, and WILBER J: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 81:407-408, 1974 LinkGoogle Scholar2. COHEN S, DIBELLA N, and MICHALAK J: Recall injury from adriamycin. Ann Intern Med 83:232, 1975 LinkGoogle Scholar3. YATES J, WALLACE H, and ELLISON R: Cytosine arabinoside and daunorubicin therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep 57:485-488, 1973 MedlineGoogle Scholar4. D'ANGIO G, FARBER S, and MADDOCK C: Potentiation of x-ray effects by Actinomycin D. Radiology 73:175-177, 1959 CrossrefMedlineGoogle Scholar5. BLUM R and CARTER S: Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80:249-259, 1974 LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: DAVID BAER, M.D.; LEE S. WILKINSON, M.D.Affiliations: Department of Internal Medicine Kaiser-Permanente Medical Center San Francisco, CA 94115 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCutaneous Reactions to Chemotherapy and their ManagementHistopathologic Features Seen with Radiation Recall or Enhancement EruptionsReducing the Morbidity From Extravasation InjuriesMethotrexate-Induced Radiation RecallSevere Tissue Necrosis After Cisplatin Extravasation at Low Concentration: Possible “Immediate Recall Phenomenon”Cutaneous complications of chemotherapeutic agentsNon-Hodgkin's lymphoma and acute myeloblastic leukemia.A report of 12 cases and review of the literatureRadiotherapy and chemotherapy in combined clinical trials: Problems and promise 1 August 1976Volume 85, Issue 2Page: 259-260KeywordsBiopsyGallium scanLaparotomyLymphomaSoft tissues ePublished: 1 December 2008 Issue Published: 1 August 1976 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
David Baer (1976) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: